GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgenic Group Inc (TSE:2342) » Definitions » ROIC %

Transgenic Group (TSE:2342) ROIC % : 0.00% (As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Transgenic Group ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Transgenic Group's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2024 was 0.00%.

As of today (2025-04-02), Transgenic Group's WACC % is 2.41%. Transgenic Group's ROIC % is 0.12% (calculated using TTM income statement data). Transgenic Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Transgenic Group ROIC % Historical Data

The historical data trend for Transgenic Group's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgenic Group ROIC % Chart

Transgenic Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.32 14.02 25.39 -0.59 0.13

Transgenic Group Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.74 -1.00 -2.12 2.86 -

Competitive Comparison of Transgenic Group's ROIC %

For the Biotechnology subindustry, Transgenic Group's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgenic Group's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's ROIC % distribution charts can be found below:

* The bar in red indicates where Transgenic Group's ROIC % falls into.


;
;

Transgenic Group ROIC % Calculation

Transgenic Group's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Mar. 2024 is calculated as:

ROIC % (A: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2023 ) + Invested Capital (A: Mar. 2024 ))/ count )
=89.436 * ( 1 - 90.74% )/( (6463.34 + 6774.003)/ 2 )
=8.2817736/6618.6715
=0.13 %

where

Invested Capital(A: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10672.931 - 750.144 - ( 3459.447 - max(0, 2743.992 - 7562.372+3459.447))
=6463.34

Invested Capital(A: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9810.999 - 558.767 - ( 2478.229 - max(0, 2434.288 - 6549.505+2478.229))
=6774.003

Transgenic Group's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2024 is calculated as:

ROIC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=0 * ( 1 - 0% )/( (6774.003 + 7407.041)/ 2 )
=0/7090.522
=0.00 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9810.999 - 558.767 - ( 2478.229 - max(0, 2434.288 - 6549.505+2478.229))
=6774.003

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10575.344 - 901.959 - ( 2266.344 - max(0, 3587.181 - 6978.779+2266.344))
=7407.041

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transgenic Group  (TSE:2342) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Transgenic Group's WACC % is 2.41%. Transgenic Group's ROIC % is 0.12% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Transgenic Group ROIC % Related Terms

Thank you for viewing the detailed overview of Transgenic Group's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgenic Group Business Description

Traded in Other Exchanges
N/A
Address
1-7-1 Yurakucho, Yurakucho Denki Building South Wing 4th Floor, Chiyoda-ku, Kobe-shi, JPN, 100-0006
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals.

Transgenic Group Headlines

No Headlines